NCT01706432

Hypofractionated Image Guided Radiation Therapy in Treating Patients With Stage IV Breast Cancer

Biologic Endpoints in the Annihilation of Metastases for Oligometastasis (BEAM ON)

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 4 (actual)
• Sponsor: University of Chicago · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This pilot clinical trial studies new ways to monitor the impact of hypofractionated image guided radiation therapy in treating patients with stage IV breast cancer. Radiation therapy uses high energy x rays to kill tumor cells. Giving radiation therapy in different ways may kill more tumor cells.

Conditions

• Central Nervous System Metastases
• Invasive Ductal Breast Carcinoma
• Invasive Ductal Breast Carcinoma With Predominant Intraductal Component
• Invasive Lobular Breast Carcinoma
• Invasive Lobular Breast Carcinoma With Predominant in Situ Component
• Liver Metastases
• Lobular Breast Carcinoma in Situ
• Lung Metastases
• Male Breast Cancer
• Medullary Ductal Breast Carcinoma With Lymphocytic Infiltrate
• Mucinous Ductal Breast Carcinoma
• Papillary Ductal Breast Carcinoma
• Recurrent Breast Cancer
• Stage IV Breast Cancer
• Tubular Ductal Breast Carcinoma
• Tumors Metastatic to Brain

Interventions

Type	Name	Description
RADIATION	hyperfractionated radiation therapy	Undergo hypofractionated radiation therapy
OTHER	laboratory biomarker analysis	Correlative studies
RADIATION	stereotactic radiosurgery	Undergo stereotactic radiosurgery

Timeline

• Start date: 2009-06-15
• Primary completion: 2024-01-22
• Completion: 2024-01-22
• First posted: 2012-10-15
• Last updated: 2024-07-31

Locations

1 site across 1 country: United States